AR and prostate carcinoma: This secretory activity is mainly dependent on hormone signalling mediated through the androgen receptor (AR), a nuclear hormone receptor transcription factor.39,40 To better understand metabolic alterations in prostate cancer cells, it is important to be familiar with the metabolism of benign prostate cells (Fig. 3).